Overview of depression and psychosis in Alzheimer's disease.
about
Alzheimer's disease: A conceptual historyDistinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological CorrelatesHallucinations, delusions, and cognitive decline in Alzheimer's diseaseDepressive symptoms in neurodegenerative diseasesNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureCognitive decline with nortriptyline use in a patient with dementia of the Alzheimer's typeRecommendations for the management of behavioral and psychological symptoms of dementia.Non-pharmacological management of behavioural symptoms of dementia.Integrity promoting care of demented patients: patterns of interaction during morning care.Relationship of exercise and other risk factors to depression of Alzheimer's disease: the LASER-AD study.Psychopharmacists' role in neuroleptic therapy. A pharmaceutical care approach.Treatment-resistant depression in late life.Depression and dementia: comorbidities, identification, and treatment.Anxiety disorders and disability secondary to urinary incontinence among adults over age 50.Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trialWhat are the causes of late-life depression?Detection of depression in older adults with dementia.Maintaining good morale in old age.Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.Metamemory experiments in neurological populations: a review.Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease.A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase.Delusions and hallucinations are associated with worse outcome in Alzheimer diseasePsychosis in elderly patients: classification and pharmacotherapy.Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study designClinical features and assessment of severe dementia. A review.Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.Influence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus.Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.Treatment of the special patient with schizophrenia.Relatives' attitudes towards informing patients about the diagnosis of Alzheimer's disease.Cerebral correlates of psychotic symptoms in Alzheimer's disease.Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.Pharmacologic management of psychosis in the elderly: a critical review.Nonpharmacologic interventions for psychotic symptoms in dementia.Behavioural disturbances in the demented elderly: phenomenology, pharmacotherapy and behavioural management.A Perspective on the Primary Care of Patients With Behavior, Mood, and Thought Disturbances: Clinical Applications of Olanzapine.Review of delusions in dementia.
P2860
Q22252906-5E012910-CAD7-4160-943A-26FED89B0950Q22299260-A536297F-F8C0-4365-850C-451AA2E31C66Q24672742-E67A14D2-B8A6-4307-AC32-2EF5BC3602ABQ26798063-5F8CABB0-7F81-4F01-8A3B-12BAEF3E3AF0Q26864905-BCE7521D-0C1D-4A7B-857E-16722B230FE8Q28324503-0EA3424F-EF92-4C8F-83FD-A11491501667Q30327961-F3A013E4-41B1-438A-A82F-7446A054E2DFQ30409197-89314EFA-49D9-4255-A97D-9907061E9DFCQ30537363-4DD83418-CE57-46B7-B732-36579DA6EAB7Q33212018-448BF6D3-EAB1-426A-9FE5-31A21EEBC6B9Q33556483-FBB58241-D605-486F-94D5-98EEADD67DD4Q33609576-A4F2BA8E-C4AA-429A-9B6F-43CFFCB43DC5Q33609585-A705E5EA-44D9-418D-A454-1283BE7683C9Q33677094-73185A9E-E366-40E4-86F2-2D68345853FCQ33737223-897E37F4-7B1C-40A2-B3CF-642A9AB57986Q33856140-E52D6FC3-C52E-4FA9-B8D1-EB17D6ED022FQ33938410-DFD28B83-51B5-4DDB-B202-E2B45CA5BD8DQ34186925-EB5C8B51-7F82-45F2-9C59-6608F6913A6DQ34192760-BDA97857-06B1-4054-9881-838DE31DD0D5Q34473016-C0C8D8C4-6865-4184-9E66-0BE5D4A213A7Q34482196-C84CD562-517E-4324-B24C-0814F1D3D55AQ34500731-F74CBFEF-B88C-4E3D-8BD1-F28669B6BC09Q34528084-5305B2C8-DFAF-4ACC-9FE3-C1A24FCDED40Q34543627-34CE5DE0-4426-4AF1-A12C-8BA790D61B9EQ34551466-034EF880-A09F-467C-A599-4361E7C2709EQ34554039-E7C4CA9A-564E-40A2-AA33-9CA4EC0E89BBQ34563065-2BE137FC-2517-4A66-BB05-72BBD034696CQ34840916-CF0370F1-2F93-4FFE-B99C-090116BE2CECQ34953672-C2C12118-A4DD-4613-A070-AE903A15BA30Q35124987-DCBBA3D7-5321-4476-97FB-7D438133DCB7Q35236370-895A10D1-F4CB-4318-88C3-63A6CB860C2DQ35424721-65F5A6BC-3045-4E66-B993-A804F333AB5EQ35458372-15CEF6B1-552E-4627-B3C0-8AB8E5265EF5Q35458761-874B832A-2795-4B11-A1B9-43A152C36247Q35469889-18DB0812-F709-4938-82A0-CD8F9B1F7F45Q35599469-74876E9C-E18F-40E6-9043-640AC4E926D1Q35599472-CB73628E-7E94-4242-9569-B6CA0EF4F0E1Q35653786-57597462-81F8-4D37-9CF6-79C680F78985Q35666903-1F8F555B-D3E8-4FB0-91C0-2039A132A8F2Q35683090-CBEF814E-CED5-4CF9-94E7-814C3D40086B
P2860
Overview of depression and psychosis in Alzheimer's disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Overview of depression and psychosis in Alzheimer's disease.
@en
type
label
Overview of depression and psychosis in Alzheimer's disease.
@en
prefLabel
Overview of depression and psychosis in Alzheimer's disease.
@en
P356
P1476
Overview of depression and psychosis in Alzheimer's disease.
@en
P2093
P304
P356
10.1176/AJP.146.5.577
P407
P577
1989-05-01T00:00:00Z